Precocious Puberty

Madhusmita Misra; Sally Radovick

doi:10.1007/978-3-031-66296-6_25

Precocious Puberty

Madhusmita Misra
, Sally Radovick

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

Precocious puberty has been a focus of interest for both the pediatric endocrinologist and the primary pediatrician for many years. The development and application of gonadotropin-releasing hormone (GnRH) agonist (GnRHa) therapy to treat central precocious puberty in the 1980s significantly changed our approach to this disorder. More recently, application of molecular biological techniques has led to a better understanding of the intricacies of regulation of gonadotropin and sex-steroid production characteristic of normal pubertal development and provided us with the tools to elucidate etiologies of previously uncharacterized disorders of precocious puberty.

Original language	English (US)
Title of host publication	Pediatric Endocrinology
Subtitle of host publication	A Practical Clinical Guide, Fourth Edition
Publisher	Springer Nature
Pages	689-720
Number of pages	32
ISBN (Electronic)	9783031662966
ISBN (Print)	9783031662959
DOIs	https://doi.org/10.1007/978-3-031-66296-6_25
State	Published - Jan 1 2024

Keywords

Androgen
Central precocious puberty (CPP)
Estrogen
Follicle-stimulating hormone (FSH)
GnRH agonist (GnRHa)
Gonadotropin-independent precocious puberty
Gonadotropin-releasing hormone (GnRH)
Luteinizing hormone (LH)
Peripheral precocious puberty
Precocious puberty

ASJC Scopus subject areas

General Medicine

Access to Document

10.1007/978-3-031-66296-6_25

Cite this

@inbook{17f855b8c23d4fdca8c1712f027bf01d,

title = "Precocious Puberty",

abstract = "Precocious puberty has been a focus of interest for both the pediatric endocrinologist and the primary pediatrician for many years. The development and application of gonadotropin-releasing hormone (GnRH) agonist (GnRHa) therapy to treat central precocious puberty in the 1980s significantly changed our approach to this disorder. More recently, application of molecular biological techniques has led to a better understanding of the intricacies of regulation of gonadotropin and sex-steroid production characteristic of normal pubertal development and provided us with the tools to elucidate etiologies of previously uncharacterized disorders of precocious puberty.",

keywords = "Androgen, Central precocious puberty (CPP), Estrogen, Follicle-stimulating hormone (FSH), GnRH agonist (GnRHa), Gonadotropin-independent precocious puberty, Gonadotropin-releasing hormone (GnRH), Luteinizing hormone (LH), Peripheral precocious puberty, Precocious puberty",

author = "Madhusmita Misra and Sally Radovick",

note = "Publisher Copyright: {\textcopyright} The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG 2003, 2013, 2018, 2024.",

year = "2024",

month = jan,

day = "1",

doi = "10.1007/978-3-031-66296-6\_25",

language = "English (US)",

isbn = "9783031662959",

pages = "689--720",

booktitle = "Pediatric Endocrinology",

publisher = "Springer Nature",

address = "United States",

}

TY - CHAP

T1 - Precocious Puberty

AU - Misra, Madhusmita

AU - Radovick, Sally

N1 - Publisher Copyright: © The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG 2003, 2013, 2018, 2024.

PY - 2024/1/1

Y1 - 2024/1/1

N2 - Precocious puberty has been a focus of interest for both the pediatric endocrinologist and the primary pediatrician for many years. The development and application of gonadotropin-releasing hormone (GnRH) agonist (GnRHa) therapy to treat central precocious puberty in the 1980s significantly changed our approach to this disorder. More recently, application of molecular biological techniques has led to a better understanding of the intricacies of regulation of gonadotropin and sex-steroid production characteristic of normal pubertal development and provided us with the tools to elucidate etiologies of previously uncharacterized disorders of precocious puberty.

AB - Precocious puberty has been a focus of interest for both the pediatric endocrinologist and the primary pediatrician for many years. The development and application of gonadotropin-releasing hormone (GnRH) agonist (GnRHa) therapy to treat central precocious puberty in the 1980s significantly changed our approach to this disorder. More recently, application of molecular biological techniques has led to a better understanding of the intricacies of regulation of gonadotropin and sex-steroid production characteristic of normal pubertal development and provided us with the tools to elucidate etiologies of previously uncharacterized disorders of precocious puberty.

KW - Androgen

KW - Central precocious puberty (CPP)

KW - Estrogen

KW - Follicle-stimulating hormone (FSH)

KW - GnRH agonist (GnRHa)

KW - Gonadotropin-independent precocious puberty

KW - Gonadotropin-releasing hormone (GnRH)

KW - Luteinizing hormone (LH)

KW - Peripheral precocious puberty

KW - Precocious puberty

UR - https://www.scopus.com/pages/publications/105013019019

UR - https://www.scopus.com/pages/publications/105013019019#tab=citedBy

U2 - 10.1007/978-3-031-66296-6_25

DO - 10.1007/978-3-031-66296-6_25

M3 - Chapter

AN - SCOPUS:105013019019

SN - 9783031662959

SP - 689

EP - 720

BT - Pediatric Endocrinology

PB - Springer Nature

ER -

Precocious Puberty

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this